Abbott India Limited (ABBOTINDIA.NS)
Company Info
Highlights
₹657.65B
₹628.40
48.85
₹48.05B
₹19.84B
₹14.66B
₹25,224.21 - ₹31,898.95
₹30,645.25
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of ₹10,000 in Abbott India Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Abbott India Limited (ABBOTINDIA.NS) returned 0.89% year-to-date (YTD) and 17.36% over the past 12 months. Over the past 10 years, ABBOTINDIA.NS delivered an annualized return of 24.08%, outperforming the S&P 500 benchmark at 10.43%.
ABBOTINDIA.NS
0.89%
2.06%
5.97%
17.36%
12.25%
24.08%
^GSPC (Benchmark)
-3.70%
13.67%
-5.18%
9.18%
14.14%
10.43%
Monthly Returns
The table below presents the monthly returns of ABBOTINDIA.NS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -12.00% | 16.13% | 1.07% | -2.39% | 0.07% | 0.89% | |||||||
| 2024 | 13.37% | 9.76% | -4.62% | -2.49% | -2.11% | 6.71% | 4.24% | 6.38% | -3.41% | -0.64% | -4.33% | 7.28% | 32.03% |
| 2023 | -2.57% | -2.91% | 9.17% | 1.05% | -2.51% | 7.73% | 3.41% | -3.98% | 0.30% | -3.30% | 6.21% | -4.01% | 7.61% |
| 2022 | -17.48% | 9.18% | 0.83% | -3.52% | 3.78% | 5.84% | 6.69% | -5.78% | 2.13% | 0.56% | 5.15% | 5.58% | 10.35% |
| 2021 | -9.81% | 1.18% | 4.13% | 1.12% | 5.79% | 4.87% | 14.12% | 1.36% | 6.46% | -2.28% | -4.80% | 2.09% | 24.67% |
| 2020 | -4.41% | 25.76% | -1.70% | 14.75% | -5.68% | -5.90% | -1.19% | 5.98% | 0.67% | -7.21% | 0.66% | 2.40% | 21.36% |
| 2019 | 7.36% | -7.84% | -1.79% | 1.60% | 4.80% | 14.28% | -5.90% | 9.57% | 15.83% | 11.12% | 6.83% | 3.95% | 74.24% |
| 2018 | 1.81% | 2.10% | -5.05% | 13.33% | 8.01% | 8.45% | 6.00% | 8.66% | -6.69% | -2.64% | -1.96% | 1.30% | 36.14% |
| 2017 | -6.79% | 1.39% | 4.02% | -4.71% | -5.56% | 2.27% | 5.01% | -6.11% | 1.39% | 0.00% | 24.65% | 4.75% | 18.10% |
| 2016 | -15.73% | -5.51% | -1.69% | -1.60% | 1.62% | -1.89% | 1.84% | -0.12% | 1.80% | 5.37% | -1.96% | -3.66% | -20.86% |
| 2015 | 4.52% | -4.63% | 4.23% | -0.31% | 2.55% | -3.61% | 15.30% | 7.68% | 18.34% | -1.78% | -6.50% | 15.19% | 59.13% |
| 2014 | -2.65% | 5.03% | 1.78% | 3.84% | -4.76% | 25.13% | -2.23% | 23.12% | 22.66% | -2.31% | 13.67% | 8.01% | 128.05% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ABBOTINDIA.NS is 74, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Abbott India Limited (ABBOTINDIA.NS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Abbott India Limited provided a 1.37% dividend yield over the last twelve months, with an annual payout of ₹410.00 per share. The company has been increasing its dividends for 3 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | ₹410.00 | ₹410.00 | ₹325.00 | ₹130.00 | ₹120.00 | ₹143.00 | ₹15.00 | ₹55.00 | ₹40.00 | ₹35.00 | ₹31.00 | ₹23.00 |
Dividend yield | 1.37% | 1.38% | 1.42% | 0.61% | 0.62% | 0.91% | 0.11% | 0.73% | 0.72% | 0.74% | 0.52% | 0.60% |
Monthly Dividends
The table displays the monthly dividend distributions for Abbott India Limited. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | |||||||
| 2024 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹410.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹410.00 |
| 2023 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹325.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹325.00 |
| 2022 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹130.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹130.00 |
| 2021 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹120.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹120.00 |
| 2020 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹143.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹143.00 |
| 2019 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹15.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹15.00 |
| 2018 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹55.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹55.00 |
| 2017 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹40.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹40.00 |
| 2016 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹35.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹35.00 |
| 2015 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹31.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹31.00 |
| 2014 | ₹23.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹23.00 |
Dividend Yield & Payout
Dividend Yield
Abbott India Limited has a dividend yield of 1.37%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Abbott India Limited has a payout ratio of 83.18%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Abbott India Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Abbott India Limited was 32.88%, occurring on Feb 8, 2022. Recovery took 336 trading sessions.
The current Abbott India Limited drawdown is 4.87%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -32.88% | Oct 6, 2021 | 86 | Feb 8, 2022 | 336 | Jun 19, 2023 | 422 |
| -32.59% | Jan 1, 2016 | 347 | May 29, 2017 | 217 | Apr 12, 2018 | 564 |
| -24.27% | Apr 20, 2012 | 232 | Mar 20, 2013 | 235 | Feb 28, 2014 | 467 |
| -22.51% | May 6, 2020 | 190 | Feb 2, 2021 | 120 | Jul 29, 2021 | 310 |
| -19.5% | Sep 11, 2018 | 30 | Oct 26, 2018 | 153 | Jun 12, 2019 | 183 |
Volatility
Volatility Chart
The current Abbott India Limited volatility is 7.48%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Abbott India Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Abbott India Limited, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 4.2% positive surprise.
Valuation
The Valuation section provides an overview of how Abbott India Limited is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for ABBOTINDIA.NS, comparing it with other companies in the Drug Manufacturers - General industry. Currently, ABBOTINDIA.NS has a P/E ratio of 48.9. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ABBOTINDIA.NS relative to other companies in the Drug Manufacturers - General industry. Currently, ABBOTINDIA.NS has a P/S ratio of 10.5. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ABBOTINDIA.NS in comparison with other companies in the Drug Manufacturers - General industry. Currently, ABBOTINDIA.NS has a P/B value of 18.4. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |